Comparison of the Etest and a rapid flow cytometry-based method with the reference CLSI broth microdilution protocol M27-A3 for the echinocandin susceptibility testing of Candida spp

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 6, 2012, Pages 941-946

  Vale Silva, L A ^a   Pinto, P ^b   Lopes, V ^b   Ramos, H ^b   Pinto, E ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b Institute of Biomedical Sciences Abel Salazar   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANIDULAFUNGIN; CASPOFUNGIN; ECHINOCANDIN; ANTIFUNGAL AGENT;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CANDIDA GLABRATA; CANDIDA KRUSEI; CANDIDA PARAPSILOSIS; CLINICAL PROTOCOL; CONTROLLED STUDY; EPSILOMETER TEST; FLOW CYTOMETRY; FUNGAL STRAIN; FUNGUS ISOLATION; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REPRODUCIBILITY; SYSTEMATIC ERROR; CANDIDA; COMPARATIVE STUDY; DRUG EFFECT; EVALUATION; HUMAN; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MYCOLOGY;

ANTIFUNGAL AGENTS; CANDIDA; ECHINOCANDINS; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOLOGY;

EID: 84863819518     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1390-z     Document Type: Article

References (27)

1. Bal AM (2010) The echinocandins: three useful choices or three too many? Int J Antimicrob Agents 35:13-18
2. Pappas PG, Kauffman CA, Andes D, Benjamin DK Jr, Calandra TF, Edwards JE Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD; Infectious Diseases Society of America (2009) Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48:503-535
3. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, van Burik JA, Wingard JR, Patterson TF; Infectious Diseases Society of America (2008) Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46:327-360 (Pubitemid 351265310)
4. Clinical and Laboratory Standards Institute (CLSI) (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved Standard-Third Edition. Document M27-A3. CLSI, Wayne, PA
5. Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST) (2008) EUCAST definitive document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts. Clin Microbiol Infect 14:398-405
6. Cuenca-Estrella M, Rodriguez-Tudela JL (2010) The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro. Expert Rev Anti Infect Ther 8:267-276
7. Clinical and Laboratory Standards Institute (CLSI) (2004) Methods for antifungal disk diffusion susceptibility testing of yeasts; Approved Standard. Document M44-A. CLSI, Wayne, PA
8. Lass-Flörl C, Perkhofer S, Mayr A (2010) In vitro susceptibility testing in fungi: a global perspective on a variety ofmethods.Mycoses 53:1-11
9. Vale-Silva LA, Buchta V (2006) Antifungal susceptibility testing by flow cytometry: is it the future? Mycoses 49:261-273 (Pubitemid 43894048)
10. Perlin DS (2007) Resistance to echinocandin-class antifungal drugs. Drug Resist Updat 10:121-130 (Pubitemid 47031054)
11. Garcia-Effron G, Park S, Perlin DS (2009) Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints. Antimicrob Agents Chemother 53:112-122
12. Garcia-Effron G, Lee S, Park S, Cleary JD, Perlin DS (2009) Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint. Antimicrob Agents Chemother 53:3690-3699
13. Garcia-Effron G, Katiyar SK, Park S, Edlind TD, Perlin DS (2008) A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility. Antimicrob Agents Chemother 52:2305-2312 (Pubitemid 351915657)
14. Garcia-Effron G, Chua DJ, Tomada JR, DiPersio J, Perlin DS, Ghannoum M, Bonilla H (2010) Novel FKS mutations associated with echinocandin resistance in Candida species. Antimicrob Agents Chemother 54:2225-2227
15. Pfeiffer CD, Garcia-Effron G, Zaas AK, Perfect JR, Perlin DS, Alexander BD (2010) Breakthrough invasive candidiasis in patients on micafungin. J Clin Microbiol 48:2373-2380
16. Chou LS, Lewis RE, Ippoliti C, Champlin RE, Kontoyiannis DP (2007) Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients. Pharmacotherapy 27:1644-1650 (Pubitemid 350234313)
17. Pfaller MA, Diekema DJ, Ostrosky-Zeichner L, Rex JH, Alexander BD, Andes D, Brown SD, ChaturvediV, GhannoumMA, Knapp CC, Sheehan DJ, Walsh TJ (2008) Correlation of MIC with outcome for Candida species tested against caspofungin, anidulafungin, and micafungin: analysis and proposal for interpretive MIC breakpoints. J Clin Microbiol 46:2620-2629
18. Thompson GR 3rd, Wiederhold NP, Vallor AC, Villareal NC, Lewis JS 2nd, Patterson TF (2008) Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection. Antimicrob Agents Chemother 52:3783-3785
19. Forrest GN, Weekes E, Johnson JK (2008) Increasing incidence of Candida parapsilosis candidemia with caspofungin usage. J Infect 56:126-129
20. Sipsas NV, Lewis RE, Tarrand J, Hachem R, Rolston KV, Raad II, Kontoyiannis DP (2009) Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer 115:4745-4752
21. Arendrup MC, Garcia-Effron G, Lass-Flörl C, Lopez AG, Rodriguez-Tudela JL, Cuenca-Estrella M, Perlin DS (2010) Echinocandin susceptibility testing of Candida species: comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, disk diffusion, and agar dilution methods with RPMI and isosensitest media. Antimicrob Agents Chemother 54:426-439
22. Pfaller MA, Castanheira M, Diekema DJ, Messer SA, Moet GJ, Jones RN (2010) Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species. J Clin Microbiol 48:1592-1599
23. Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Jones RN, Turnidge J, Diekema DJ (2010) Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp. J Clin Microbiol 48:52-56
24. Green L, Petersen B, Steimel L, Haeber P, Current W (1994) Rapid determination of antifungal activity by flow cytometry. J Clin Microbiol 32:1088-1091 (Pubitemid 24100099)
25. Mitchell M, Hudspeth M, Wright A (2005) Flow cytometry susceptibility testing for the antifungal caspofungin. J Clin Microbiol 43:2586-2589 (Pubitemid 40827924)
26. Pina-Vaz C, Costa-de-Oliveira S, Rodrigues AG, Espinel- Ingroff A (2005) Comparison of two probes for testing susceptibilities of pathogenic yeasts to voriconazole, itraconazole, and caspofungin by flow cytometry. J Clin Microbiol 43:4674-4679 (Pubitemid 41298261)
27. Rudensky B, Broidie E, Yinnon AM, Weitzman T, Paz E, Keller N, Raveh D (2005) Rapid flow-cytometric susceptibility testing of Candida species. J Antimicrob Chemother 55:106-109 (Pubitemid 40192622)